FDA approves new drug for ALS treatment that costs $145,524 annually.
A team of researchers from the University Medical Center Utreacht has devised a way for locked-in ALS patients to communicate with other people. The technology uses a brain implant, which enables the patient to control a computer with his or her mind.
A new brain implant has allowed an ALS (amyotrophic lateral sclerosis) patient to be the first woman to use an eye tracking device that takes a minute to spell a word.
A new study revealed that adding fruits and vegetables rich with antioxidant nutrients and carotenoids to the daily diet of patients suffering from amyotrophic lateral sclerosis (ALS) could slow the progression of the neurological disorder.